Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Seralutinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 93,099Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Gossamer Bio Announces Inducement Grant Under Nasdaq LR 5635(c)(4)
    Gossamer Bio Announces Inducement Grant Under Nasdaq LR 5635(c)(4)

    07 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250207717407/en

    BUSINESSWIRE
    07 Feb 2025
    Share Share
    Gossamer Bio Announces Inducement Grant Under Nasdaq Rule 5635(c)(4)
    Gossamer Bio Announces Inducement Grant Under Nasdaq Rule 5635(c)(4)

    07 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241007084198/en

    BUSINESSWIRE
    07 Oct 2024
    Share Share
    Gossamer To Provide Seralutinib OLE Data At ATS 2024
    Gossamer To Provide Seralutinib OLE Data At ATS 2024

    14 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240514616477/en

    BUSINESSWIRE
    14 May 2024
    Share Share
    Chiesi and Gossamer Bio collaborate to develop Seralutinib for PAH
    Chiesi and Gossamer Bio collaborate to develop Seralutinib for PAH

    06 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/chiesi-and-gossamer-bio-announce-transformative-global-collaboration-to-develop-and-commercialize-seralutinib-in-pulmonary-arterial-hypertension-and-other-respiratory-indications-302136742.html

    PR NEWSWIRE
    06 May 2024
    Share Share
    Gossamer Bio to Host Webcast to Discuss Seralutinib Open-Label Extension Data
    Gossamer Bio to Host Webcast to Discuss Seralutinib Open-Label Extension Data

    13 Dec 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231213371661/en

    BUSINESSWIRE
    13 Dec 2023
    Share Share
    Gossamer Announces Seralutinib Meets Endpoint in PII TORREY Study in PAH
    Gossamer Announces Seralutinib Meets Endpoint in PII TORREY Study in PAH

    06 Dec 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221206005388/en

    BUSINESSWIRE
    06 Dec 2022
    Share Share